Timo Soeterik

79 Impact of MRI on Risk Classification SUPPLEMENTARY TABLE S4. Baseline characteristics of patients that did not undergo mpMRI N (%) Patients 646 Age (median, IQR) 73 (67 - 78) PSA (median, IQR) 10.5 (6.6 – 25.0) Clinical T-stage T1 T2a T2b T2c T3/T4 Unknown 256 (40) 177 (27) 38 (6) 41 (6) 128 (20) 6 (1) Highest biopsy ISUP grade 1 2 3 4 5 Unknown 206 (32) 159 (25) 87 (13) 161 (25) 25 (4) 8 (1) Risk group (DRE) Low Intermediate High (localized) High (locally advanced) Unknown 137 (21) 191 (30) 148 (23) 151 (23) 19 (3) Clinical N stage N0 N1 NX Unknown 222 (34) 57 (9) 365 (57) 2 (0) 4